Sepsi e SIRS: un focus sull'ecocardiografia in ambito clinico
Contenuto principale dell'articolo
Abstract
La presente revisione narrativa mira a concentrarsi sul processo diagnostico in caso di pazienti con SIRS (sindrome da risposta infiammatoria sistemica) o sepsi che confermano o escludono la diagnosi concomitante di endocardite infettiva. Ci siamo concentrati sulle indicazioni adeguate per l'ecocardiografia transtoracica e transesofagea nei pazienti SIRS / settici, rivedendo la letteratura scientifica e le linee guida internazionali aggiornate sugli argomenti. Suggeriamo uno strumento di diagramma di flusso per assistere durante il processo diagnostico dell'endocardite infettiva, incluso un uso adeguato dell'ecocardiografia.
Downloads
Dettagli dell'articolo
Questo lavoro è fornito con la licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 4.0 Internazionale.
Riferimenti bibliografici
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Singer M. et al.
Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-874.
Vincent JL, Moreno R, Takala J, et al; Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710.
Shankar-HariM, Phillips G, LevyML, et al Assessment of definition and clinical criteria for septic shock. JAMA.doi:10.1001/jama.2016.0289
N Engl J Med. 2003 Apr 17;348(16):1546-54. The epidemiology of sepsis in the United States from 1979 through 2000. Martin GS1, Mannino DM, Eaton S, Moss M.
Intensive Care Med. 1995 Nov;21 Suppl 2:S244-9. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Salvo I1, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, Montani C, Magni E.
Crit Care. 2004 Aug;8(4):R180-4. Epub 2004 May 14. Epidemiology of sepsis in Norway in 1999. Flaatten H.
Crit Care. 2004 Aug;8(4):R153-62. Epub 2004 May 14. Prevalence and incidence of severe sepsis in Dutch intensive care units. van Gestel A, Bakker J, Veraart CP, van Hout BA.
National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Torio CM, Andrews RM. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006-.
Aug.
Intensive Care Med. 2016 Oct;42(10):1641-2. doi: 10.1007/s00134-016-4442-0. Epub 2016 Jul 9. Chronic healthcare expenditure in survivors of sepsis in the intensive care unit. Koster-Brouwer ME et al
Lancet. 2016 Feb 27;387(10021):882-93. doi: 10.1016/S0140-6736(15)00067-7. Epub 2015 Sep 1. Infective endocarditis. Cahill TJ, Prendergast BD.
J Clin Med Res. 2017 Sep;9(9):754-758. doi: 10.14740/jocmr3131w. Epub 2017 Jul 27. Epidemiology of Infective Endocarditis in Rural Upstate New York, 2011 – 2016. Fatima S et al.
Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002;288:75–81.
Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of population-based studies of infective endocarditis. Chest 2007;132(3):1025–1035.
Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA 1985;254:1199–1202.
Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J 1995;16 (SupplB):2–9.
Weinberger I, Rotenberg Z, Zacharovitch D, et al. Native valve infective endocarditis in the 1970s versus 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol 1990;13:94–8.
Clemens JD, Horwitz RI, Jaffe CC, et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med 1982;307:776–80
Bashore TM, Cabell C, Fowler VJ Jr. Update on infective endocarditis. Curr Probl Cardiol 2006;4:274– 352.
Mourvillier B, Trouillet JL, Timsit JF, et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med 2004;30:2046–52.
Karth GD, Koreny M, Binder T, et al. Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care 2002;6:149–54.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200–7
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633–8
Crit Care. 2002; 6(2): 149–154. Published online 2002 Mar 6.PMCID: PMC111181 Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis Delle Karth G.
Crit Care Clin. 2000 Apr;16(2):337-52, vii. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Balk RA.
Am J Health Syst Pharm. 2002 Feb 15;59 Suppl 1:S13-9. Optimal antimicrobial therapy for sepsis. Fish DN.
Eur Heart J. 2013 Jul;34(26):1999-2006. doi: 10.1093/eurheartj/ehs336. Epub 2012 Oct 11. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Olmos C. et al.
Crit Care Clin. 2010 Apr;26(2):365-82, table of contents. doi: 10.1016/j.ccc.2010.01.001.
The role of echocardiography in hemodynamic assessment of septic shock.
Griffee MJ
Wien Klin Wochenschr. 2016 Nov;128(21-22):796-801. Epub 2016 Sep 26. Fever of unknown origin (FUO) revised. Unger M.
Medicine (Baltimore). 1961 Feb;40:1-30. Fever of unexplained origin: report on 100 cases. Petersdorf RG, Beeson PB.
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al.; ESC Committee for Practice Guidelines (CPG). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369–413
Habib G. et al. Recommendations for the practice of echocardiography in infective endocarditis
European Journal of Echocardiography (2010) 11 , 202–219 doi:10.1093/ejechocard/jeq004
Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-73.
Gaca JG, Sheng S, Daneshmand M, et al. Current outcomes for tricuspid valve infective endocarditis surgery in North America. Ann Thorac Surg 2013;96:1374-81
Baraki H, Saito S, Al Ahmad A, et al. Surgical treatment for isolated tricuspid valve endocarditis- long-term follow- up at a single institution. Circ J 2013;77:2032-7.
Shrestha NK, Jue J, Hussain ST, Jerry JM, et al. Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg 2015;100:875-82.